Driving reinvestment in R&D for antibiotics and advocating their responsible use

DRIVE-AB Steering Committee Publishes Advice to G20 Leaders in The Lancet Infectious Diseases

In anticipation of the 2017 G20 Summit in Hamburg, Germany, on 7-8 July, the DRIVE-AB Steering Committee has published a commentary in The Lancet Infectious Diseases  today, 6 July, titled “To the G20 – Next steps for incentivizing antibacterial R&D”.

The commentary outlines a sample of preliminary recommendations and next steps that are relevant to the ongoing G20 proceedings and to G20 leaders. More detailed results and recommendations from the DRIVE-AB consortium as a whole will be presented at the final DRIVE-AB conference, “Revitalizing the Antibiotic Pipeline”, in Brussels on 5-6 September 2017.

Click here to read the commentary.